脑血管支架市场规模、份额和成长分析（按材质、最终用户和地区划分）—2026-2033年产业预测

预计到 2024 年，全球脑血管支架市场规模将达到 4.3 亿美元，到 2025 年将达到 4.7 亿美元，到 2033 年将达到 8.9 亿美元，预测期（2026-2033 年）的复合年增长率为 8.3%。

用于治疗脑动脉瘤和维持受损动脉血流的微型网状管状器械—脑血管支架的全球市场预计将迎来显着成长。这一增长主要受脑部疾病发病率上升和人口老化所驱动。医疗技术的进步和生物可吸收支架的日益普及为市场相关人员带来了新的机会。此外，微创手术的日益普及预计将进一步推动未来对这些支架的需求。然而，高成本以及某些支架相关的手术併发症风险等挑战可能会阻碍市场发展。儘管如此，越来越多的创新脑部治疗方法核准预计将进一步推动脑血管支架的销售。

全球脑血管支架市场驱动因素

全球老年人口的不断增长显着推高了脑血管治疗的需求。随着老年人口的增加，与老龄化相关的健康问题也随之增多，这些问题可能需要进行脑血管支架植入等干预措施。这一趋势凸显了针对老年患者特定需求的先进医疗解决方案的重要性，并最终推动了脑血管支架市场的扩张。因此，医疗服务提供者和製造商必须透过创新和改进治疗方案来满足这一日益增长的需求，从而提高脑血管疾病高风险患者的整体医疗品质。

限制全球脑血管支架市场的因素

由于脑部手术费用高昂，全球脑血管支架市场面临严峻挑战。这些手术需要先进的医疗技术和经验丰富的医护人员，导致病患整体费用增加。因此，脑部手术带来的经济负担成为潜在患者选择支架植入的障碍，可能对脑血管支架的销售预测产生不利影响。此外，复杂的手术操作及其高昂的费用也严重阻碍因素了市场成长和脑血管治疗的可及性。

脑血管支架市场的全球趋势

全球脑血管支架市场正迅速转型为生物可吸收支架和药物释放型支架等创新解决方案。製造商正优先研发采用生物可吸收材料製成的支架，这些支架在完成其治疗任务后可在体内安全溶解，无需后续手术取出。这一趋势不仅提高了患者的安全性和舒适度，还有助于降低与传统支架取出手术相关的医疗成本。此外，生物可吸收材料与药物释放型功能的融合也在不断推进，旨在改善治疗效果并拓展脑血管疾病的治疗选择。这正在彻底改变整个脑血管介入治疗领域。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球脑血管支架市场规模（按材料和复合年增长率划分）（2026-2033 年）

• 钽
• 不銹钢
• 镍钛诺

全球脑血管支架市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 医疗中心
• 其他的

全球脑血管支架市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic plc（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Stryker Corporation（USA）
• Johnson & Johnson（USA）
• MicroPort Scientific Corporation（China）
• Penumbra, Inc.（USA）
• Asahi Intecc Co., Ltd.（Japan）
• Integer Holdings Corporation（USA）
• B. Braun Melsungen AG（Germany）
• Biotronik SE & Co. KG（Germany）
• Merit Medical Systems, Inc.（USA）
• Kaneka Medix Corp.（Japan）
• Acandis GmbH（Germany）
• Balt（Switzerland）
• Rapid Medical（Israel）
• Medinol Ltd.（Israel）

结论与建议

Global Cerebral Vascular Stent Market size was valued at USD 0.43 Billion in 2024 and is poised to grow from USD 0.47 Billion in 2025 to USD 0.89 Billion by 2033, growing at a CAGR of 8.3% during the forecast period (2026-2033).

The global market for cerebral vascular stents, small mesh-like tubes used to treat brain aneurysms and maintain blood flow in compromised arteries, is poised for significant growth. This expansion is primarily driven by the rising prevalence of cerebral disorders and an aging population. Healthcare advancements and the increasing adoption of bioabsorbable stents present new opportunities for market players. Additionally, the trend towards minimally invasive surgeries stands to elevate the demand for these stents over time. However, challenges such as the high costs associated with certain stents and the risk of procedural complications may hinder market progress. On a positive note, the growing number of approvals for innovative cerebral treatment methods is expected to further enhance sales of cerebral vascular stents.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cerebral Vascular Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cerebral Vascular Stent Market Segments Analysis

Global Cerebral Vascular Stent Market is segmented by Material, End User and region. Based on Material, the market is segmented into Tantalum, Stainless Steel and Nitinol. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Medical Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cerebral Vascular Stent Market

The rising global population of older individuals significantly contributes to an increased demand for cerebral and vascular treatments. As this demographic grows, the likelihood of age-related health issues, including those requiring interventions like cerebral vascular stenting, becomes more pronounced. This trend highlights the importance of advanced medical solutions to address the specific needs of aging patients, ultimately driving the expansion of the cerebral vascular stent market. Consequently, healthcare providers and manufacturers are compelled to respond to this growing demand by innovating and improving treatment options, thereby enhancing the overall quality of care for patients at risk of cerebral vascular conditions.

Restraints in the Global Cerebral Vascular Stent Market

The global market for cerebral vascular stents faces significant challenges due to the high expenses associated with brain-related surgeries. These procedures demand advanced medical technologies and require highly skilled healthcare professionals, leading to increased overall costs for patients. As a result, the financial burden associated with cerebral procedures may deter potential patients from opting for stent placements, thereby negatively influencing the sales forecast for cerebral vascular stents. The combination of intricate medical interventions and their associated high costs poses a considerable restraint on market growth and accessibility for those in need of cerebral vascular solutions.

Market Trends of the Global Cerebral Vascular Stent Market

The Global Cerebral Vascular Stent market is increasingly gravitating towards innovative solutions such as bioabsorbable stents and drug-eluting stent technologies. Manufacturers are prioritizing the development of stents crafted from bioabsorbable materials, which eliminate the need for subsequent surgical extraction by safely dissolving in the body after fulfilling their purpose. This trend not only enhances patient safety and comfort but also reduces healthcare costs associated with traditional stent removal procedures. Additionally, the integration of drug-eluting functionalities with bioabsorbable materials is gaining momentum, aimed at improving therapeutic outcomes and expanding treatment options for cerebrovascular conditions, thereby transforming the landscape of cerebral vascular interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Cerebral Vascular Stent Market Size by Material & CAGR (2026-2033)

• Market Overview
• Tantalum
• Stainless Steel
• Nitinol

Global Cerebral Vascular Stent Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Medical Centres
• Others

Global Cerebral Vascular Stent Market Size & CAGR (2026-2033)

• North America (Material, End User)
  • US
  • Canada
• Europe (Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penumbra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Intecc Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integer Holdings Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Medix Corp. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balt (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medinol Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations